240 related articles for article (PubMed ID: 9925665)
1. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.
Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ
J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.
Calabresi L; Franceschini G; Sirtori CR; De Palma A; Saresella M; Ferrante P; Taramelli D
Biochem Biophys Res Commun; 1997 Sep; 238(1):61-5. PubMed ID: 9299452
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression.
Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ
J Lipid Res; 2000 Aug; 41(8):1261-7. PubMed ID: 10946014
[TBL] [Abstract][Full Text] [Related]
4. Lack of inhibitory effect of HDL on TNFalpha-induced adhesion molecule expression in human aortic endothelial cells.
Zhang WJ; Stocker R; McCall MR; Forte TM; Frei B
Atherosclerosis; 2002 Dec; 165(2):241-9. PubMed ID: 12417274
[TBL] [Abstract][Full Text] [Related]
5. Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins.
Clay MA; Pyle DH; Rye KA; Vadas MA; Gamble JR; Barter PJ
Atherosclerosis; 2001 Jul; 157(1):23-9. PubMed ID: 11427200
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells.
Ashby DT; Rye KA; Clay MA; Vadas MA; Gamble JR; Barter PJ
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1450-5. PubMed ID: 9743234
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression.
Ashby D; Gamble J; Vadas M; Fidge N; Siggins S; Rye K; Barter PJ
Atherosclerosis; 2001 Jan; 154(1):113-21. PubMed ID: 11137089
[TBL] [Abstract][Full Text] [Related]
8. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
Settasatian N; Barter PJ; Rye KA
J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
[TBL] [Abstract][Full Text] [Related]
9. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.
Clay MA; Pyle DH; Rye KA; Barter PJ
J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751
[TBL] [Abstract][Full Text] [Related]
10. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.
Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA
Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776
[TBL] [Abstract][Full Text] [Related]
11. Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II.
Hime NJ; Barter PJ; Rye KA
Biochemistry; 2001 May; 40(18):5496-505. PubMed ID: 11331014
[TBL] [Abstract][Full Text] [Related]
12. Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.
Rye KA; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter PJ
Biochemistry; 2002 Oct; 41(41):12538-45. PubMed ID: 12369845
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA
Circ Res; 2013 Jan; 112(2):278-88. PubMed ID: 23123430
[TBL] [Abstract][Full Text] [Related]
14. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA
Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025
[TBL] [Abstract][Full Text] [Related]
15. Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.
Hime NJ; Drew KJ; Wee K; Barter PJ; Rye KA
J Lipid Res; 2006 Jan; 47(1):115-22. PubMed ID: 16222033
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C
Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275
[TBL] [Abstract][Full Text] [Related]
17. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins.
Rye KA; Hime NJ; Barter PJ
J Biol Chem; 1996 Feb; 271(8):4243-50. PubMed ID: 8626769
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory functions of apolipoprotein A-I and high-density lipoprotein are preserved in trimeric apolipoprotein A-I.
Murphy AJ; Hoang A; Aprico A; Sviridov D; Chin-Dusting J
J Pharmacol Exp Ther; 2013 Jan; 344(1):41-9. PubMed ID: 23033374
[TBL] [Abstract][Full Text] [Related]
19. The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins.
Rye KA; Hime NJ; Barter PJ
J Biol Chem; 1995 Jan; 270(1):189-96. PubMed ID: 7814372
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of apolipoprotein A-I in the rabbit.
Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA
Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
